Dosing Protocols in Research Most gene expression studies used GHK-Cu at concentrations equivalent to: Subcutaneous injection: 12 mg/day (common biohacking protocol) Topical application: 15% concentration creams/serums (skin-focused gene effects) In vitro concentrations: 10100 nM range in cell studies For subcutaneous use, peptide community protocols typically run: Dose: 12 mg/day Cycle: 3090 days on, 30 days off Injection site: Subcutaneous, rotating sites Common stack: GHK-Cu + BPC-157 (synergistic tissue repair), GHK-Cu + MOTS-C (longevity stack), GHK-Cu + Retatrutide (body recomposition with connective tissue support) Topical use is effective for skin-specific outcomes
Blood vessel and nerve growth stimulation GHK-Cu promotes VEGF (vascular endothelial growth factor) production, which drives new blood vessel formation around hair follicles
Refrigeration requirements Refrigeration is essential
Int J Radiat Oncol Biol Phys 97(4):770-777, 2017
596 In ZD, miR-193b was observed to be silenced by methylation, which increases ZIP5 expression
Get Safe and Effective Peptide Therapy in NYC If you are ready to slow or even reverse the aging process, Invita Wellness is your one-stop-shop for anti-aging remedies and wellness solutions